下载App
扫码立即下载
  • 下载App

    扫码立即下载

  • 在线客服

    登录后咨询在线客服
+
恭喜您!
成功领取价值超 5000港元/年的高级行情
前往体验 >>
公司概况 更多
石四药集团有限公司,前称为利君国际医药(控股)有限公司,是一家主要从事研究、开发、制造及向医院及分销商销售药物产品的投资控股公司。公司的产品主要包括静脉输液的成药、原料药及医用材料。该公司的产品主要包括非聚氯乙烯软袋输液、聚丙烯塑瓶输液和玻璃瓶输液。该公司的产品还包括盐酸倍他司汀、盐酸氨溴索、盐酸罗哌卡因和多索茶碱以及原料药,包括咖啡因、茶碱、氨茶碱、甲硝唑和硝苯地平。
董事长: 曲继广
所属市场: 香港主板
上市日期: 2005/12/20
富途热股榜
港股美股沪深
交易热度搜索热度资讯热度
名称代码最新价涨跌幅

加载中...

自选
02005 石四药集团
3.560-0.080-2.20%
显示同比
不显示
隐藏空行
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Cash flow from operating activities
Earning before tax
30.77% 9.48亿 -- -- -46.72% 7.25亿 -- --
Profit adjustment
Interest (income) - adjustment
-7.53% -2,470.7万 -- -- 1.67% -2,297.7万 -- --
Attributable subsidiary (profit) loss
-- -542.6万 -- -- -- -- -- --
Impairment and provisions:
560.19% 149.1万 -- 0 -102.78% -32.4万 -- 0
-Impairment of trade receivables (reversal)
511.45% 136.6万 -- -- -112.18% -33.2万 -- --
-Other impairments and provisions
1462.5% 12.5万 -- -- -99.91% 8,000 -- --
Revaluation surplus:
-- 0 -- 0 -- 0 -- 0
Asset sale loss (gain):
99.71% -6,000 -- 0 98.44% -205.5万 -- 0
-Loss (gain) on sale of property, machinery and equipment
99.71% -6,000 -- -- 98.44% -205.5万 -- --
Depreciation and amortization:
24.68% 3.79亿 -- 0 10.72% 3.04亿 -- 0
-Depreciation
24.26% 3.75亿 -- -- 15.25% 3.01亿 -- --
-Amortization of intangible assets
-10.3% 1,430.1万 -- -- 7.58% 1,594.3万 -- --
-Other depreciation and amortization
26.38% -984.4万 -- -- -643.72% -1,337.2万 -- --
Financial expense
19.09% 6,129.8万 -- -- -6.87% 5,147.2万 -- --
Special items
-- 5,633.4万 -- -- -- -- -- --
Operating profit before the change of operating capital
34.21% 14.16亿 -- 0 -31.79% 10.55亿 -- 0
Change of operating capital
Inventory (increase) decrease
7.28% -1.73亿 -- -- -87.85% -1.86亿 -- --
Accounts receivable (increase)decrease
-161.32% -5.36亿 -- -- 64.19% -2.05亿 -- --
Accounts payable increase (decrease)
111.32% 1.86亿 -- -- 115.9% 8,783.3万 -- --
prepayments (increase)decrease
59.31% -1,103万 -- -- -1.22% -2,710.5万 -- --
Cash  from business operations
25.13% 9.01亿 8.22% 2.6亿 -20.43% 7.2亿 -13.69% 2.4亿
Other taxs
11.65% -1.43亿 -4.79% -1.12亿 21.67% -1.62亿 1.69% -1.07亿
Interest paid - operating
-16.24% -6,285万 -21.51% -2,842.2万 -2.21% -5,407万 3.97% -2,339.1万
Special items of business
527.61% 1,881.5万 -- -- -14093.55% -440万 -- --
Net cash from operations
37.87% 6.96亿 8.73% 1.2亿 -21.89% 5.05亿 -24.28% 1.1亿
Cash flow from investment activities
Interest received - investment
7.53% 2,470.7万 -- -- -1.67% 2,297.7万 -- --
Decrease in deposits (increase)
288.97% 8,440.5万 -- -- -165.61% -4,466.5万 -- --
Sale of fixed assets
36.04% 45.3万 -- -- 505.45% 33.3万 -- --
Purchase of fixed assets
20.96% -1.7亿 -134.12% -9,143万 71.81% -2.15亿 89.96% -3,905.3万
Purchase of intangible assets
-104.64% -2.19亿 -82.19% -8,458.9万 -43.31% -1.07亿 -152.1% -4,642.9万
Acquisition of subsidiaries
-- -4.27亿 -- -- -- -- -- --
Other items in the investment business
63.05% 4,971.8万 14440.47% 1.05亿 55.11% 3,049.3万 -106.53% -72.9万
Net cash from investment operations
-110.16% -6.57亿 17.09% -7,147.7万 56.99% -3.12亿 80.55% -8,621.1万
Net cash before financing
-79.65% 3,910.2万 102.6% 4,803.7万 339.39% 1.92亿 107.95% 2,371万
Cash flow from financing activities
New borrowing
33.45% 22.21亿 -5.36% 9.58亿 80.81% 16.64亿 110.87% 10.12亿
Refund
-59.93% -15.88亿 -74.86% -9.28亿 -40.59% -9.93亿 -33.32% -5.31亿
Issuing shares
-- -- -- -- 60% 8,256万 -- --
Dividends paid - financing
8.2% -3.06亿 15.17% -1.54亿 -10.07% -3.33亿 -20.66% -1.82亿
Issuance expenses and redemption of securities expenses
-89.77% -1.88亿 -- -- -873.82% -9,886.2万 -- --
Other items of the financing business
-108.97% -394.5万 -397.13% -7,964万 -28.12% 4,396.4万 -790% -1,602万
Net cash from financing operations
-62.84% 1.36亿 -171.94% -2.04亿 2421.53% 3.66亿 4746.59% 2.84亿
Effect of rate
-41.96% 4,059.9万 159.3% 1,215.3万 470.38% 6,995万 -42.86% -2,049.3万
Net Cash
-68.63% 1.75亿 -150.76% -1.56亿 949.51% 5.59亿 201.04% 3.07亿
Begining period cash
76.88% 14.46亿 76.88% 14.46亿 -9.38% 8.17亿 -9.38% 8.17亿
Cash at the end
14.93% 16.62亿 17.91% 13.02亿 76.88% 14.46亿 89.24% 11.04亿
Cash balance analysis
Cash and cash equivalent balance
-- 0 -- 0 -- 0 -- 0
Currency Unit
港元港元港元港元
Accounting Standards
香港会计准则香港会计准则香港会计准则香港会计准则
Audit Opinions
无保留意见--无保留意见--
Auditor
毕马威会计师事务所--毕马威会计师事务所--

Q6、Q9、FY为累计季报:Q6 为中期报告;Q9 为第三季报;FY为年报。

环比数据来源于季报,环比 = (本期 - 上期)/上期 * 100%

回到顶部